Home Galapagos, GSK successfully conclude phase 2a study of skin disease drug
 

Keywords :   


Galapagos, GSK successfully conclude phase 2a study of skin disease drug

2014-04-17 09:46:53| Biotech - Topix.net

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.

Tags: study skin drug phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.10Eastern North Pacific Tropical Weather Outlook
01.10Atlantic Tropical Weather Outlook
01.10Tropical Storm Kirk Graphics
01.10Tropical Storm Kirk Forecast Discussion Number 6
01.10Tropical Storm Kirk Wind Speed Probabilities Number 6
01.10Tropical Storm Kirk Public Advisory Number 6
01.10Summary for Tropical Storm Kirk (AT2/AL122024)
01.10Tropical Storm Kirk Forecast Advisory Number 6
More »